Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Marketable Equity Securities — Fair Value by Year
Marketable Equity Securities — Fair Value ($M)
Elevance Health Marketable Equity Securities — Fair Value: $740M in FY2025, down 37.9% from a year earlier.
Latest, FY2025
740
Period ended Dec 31, 2025
Change on a year earlier
-37.9%
1,192 in FY2024
History
8 years
Since FY2018
Sources
2
Documents cited below
Where the FY2025 figure comes from
“us-gaap:EquitySecuritiesFvNi (2025-12-31): 740,000,000.00”
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Marketable Equity Securities — Fair Value ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 740 | -37.9% | ELV 10-Q (XBRL us-gaap:EquitySecuritiesFvNi) ↗ |
| FY2024 | Dec 31, 2024 | 1,192 | +420.5% | ELV 10-K (XBRL us-gaap:EquitySecuritiesFvNi) ↗ |
| FY2023 | Dec 31, 2023 | 229 | -76.0% | ELV 10-K (XBRL us-gaap:EquitySecuritiesFvNi) ↗ |
| FY2022 | Dec 31, 2022 | 953 | -49.3% | ELV 10-K (XBRL us-gaap:EquitySecuritiesFvNi) ↗ |
| FY2021 | Dec 31, 2021 | 1,881 | +20.7% | ELV 10-Q (XBRL us-gaap:EquitySecuritiesFvNi) ↗ |
| FY2020 | Dec 31, 2020 | 1,559 | +54.5% | ELV 10-K (XBRL us-gaap:EquitySecuritiesFvNi) ↗ |
| FY2019 | Dec 31, 2019 | 1,009 | -32.4% | ELV 10-K (XBRL us-gaap:EquitySecuritiesFvNi) ↗ |
| FY2018 | Dec 31, 2018 | 1,493 | – | ELV 10-K (XBRL us-gaap:EquitySecuritiesFvNi) ↗ |
Cite this data
StockData. (2026). Elevance Health Marketable Equity Securities — Fair Value ($M), annual FY2018–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/inv-equity-securities-fv
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.